– Notice of allowance received by Company’s licensor, The University of Sheffield (UK) bolsters intellectual property ofAEZS-150 in development for the potential treatment of chronic hypoparathyroidism–
Read more at globenewswire.comProvided Content: Content provided by Globe Newswire. The Globe and Mail was not involved, and material was not reviewed prior to publication.